EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis

Kazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Akiko Wakuta; Ayano Oonishi; Teiji Kuzuya; Hidenori Toyoda; Toshifumi Tada; Kunihiko Tsuji; Ei Itobayashi; Toru Ishikawa; Koichi Takaguchi; Akemi Tsutsui; Noritomo Shimada; Masatoshi Kudo; Takashi Kumada

doi:10.1159/000508971

Related publications

Article2018

Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients

Atsushi Hiraoka, Takashi Kumada, Kojiro Michitaka, Masatoshi Kudo

Article2021

ALBI score and outcomes in patients with hepatocellular carcinoma: <i>post hoc</i> analysis of the randomized controlled trial KEYNOTE-240

Arndt Vogel, Philippe Merle, Chris Verslype, Richard S. Finn, Andrew X. Zhu, Ann‐Lii Cheng, Stephen L. Chan, Thomas Yau, Baek‐Yeol Ryoo, Jennifer J. Knox, Bruno Daniele, Shukui Qin, Ziwen Wei, Yanna R. Miteva, Usha Malhotra, Abby B. Siegel, Masatoshi Kudo

Article2019

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study

Kazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara, Tomoko Aoki, Tomohiro Minami, Hirokazu Chishina, Masahiro Takita, Yasunori Minami, Hiroshi Ida, Mamoru Takenaka, Toshiharu Sakurai, Tomohiro Watanabe, Masahiro Morita, Chikara Ogawa, Atsushi Hiraoka, Philip J. Johnson, Masatoshi Kudo

Editorial Material2021

Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma

Masatoshi Kudo

Article2020

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

Masatoshi Kudo, Peter R. Galle, Giovanni Brandi, Yoon‐Koo Kang, Chia-Jui Yen, Richard S. Finn, Josep M. Llovet, Éric Assenat, Philippe Merle, Stephen L. Chan, Daniel H. Palmer, Masafumi Ikeda, Tatsuya Yamashita, Arndt Vogel, Yi‐Hsiang Huang, Paolo Abada, Reigetsu Yoshikawa, Kenta Shinozaki, Chunxiao Wang, Ryan C. Widau, Andrew X. Zhu

JHEP Reports